UnitedHealth Group Incorporated (UNH) Holdings Reduced by Chicago Equity Partners LLC
Chicago Equity Partners LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.7% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 91,270 shares of the healthcare conglomerate’s stock after selling 4,510 shares during the quarter. Chicago Equity Partners LLC’s holdings in UnitedHealth Group were worth $16,923,000 as of its most recent filing with the SEC.
Other institutional investors have also bought and sold shares of the company. Patriot Financial Group Insurance Agency LLC boosted its stake in UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after purchasing an additional 603 shares in the last quarter. Blue Chip Partners Inc. acquired a new position in UnitedHealth Group in the second quarter worth $110,000. Kings Point Capital Management boosted its stake in UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after purchasing an additional 150 shares in the last quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its stake in UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after purchasing an additional 520 shares in the last quarter. Finally, BDO Wealth Advisors LLC acquired a new position in UnitedHealth Group in the second quarter worth $121,000. 86.14% of the stock is currently owned by institutional investors.
Shares of UnitedHealth Group Incorporated (NYSE UNH) opened at $212.87 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $136.22 and a fifty-two week high of $213.83. The stock has a market capitalization of $205,815.48, a PE ratio of 22.17, a price-to-earnings-growth ratio of 1.58 and a beta of 0.64. The company has a quick ratio of 0.72, a current ratio of 0.70 and a debt-to-equity ratio of 0.52.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. UnitedHealth Group’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the company earned $2.17 earnings per share. sell-side analysts predict that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.
Several equities analysts have recently issued reports on the company. Cowen and Company reaffirmed an “outperform” rating and set a $220.00 price target (up previously from $175.00) on shares of UnitedHealth Group in a research note on Friday, August 11th. Credit Suisse Group assumed coverage on UnitedHealth Group in a research note on Thursday. They set an “outperform” rating and a $233.00 price target on the stock. Oppenheimer Holdings, Inc. upped their price target on UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a research note on Wednesday, October 18th. Mizuho reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Tuesday, October 24th. Finally, Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Three investment analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $216.65.
In related news, insider Larry C. Renfro sold 50,574 shares of the stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the transaction, the insider now directly owns 195,625 shares in the company, valued at $38,755,268.75. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Thomas E. Roos sold 975 shares of the stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the transaction, the insider now owns 24,630 shares of the company’s stock, valued at $5,060,726.10. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 72,149 shares of company stock valued at $14,212,342. 0.89% of the stock is owned by corporate insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.